MAT 8hr Buprenorphine Training for Medical Students 2026
Updated | Download to score A+
A 28-year-old man has had 3 supervised medical withdrawal treatments for
opioid addiction with relapses shortly after discharge. The treatment with the
strongest evidence of effective ent would be:
A. Therapeutic community
B. Intensive outpatient counseling
C. Medication Assisted Treatment (MAT)
D. Medical withdrawal from opioids
C. Medication Assisted Treatment (MAT)
The DATA 2000 law allows for the prescriptions of all of the following except:
A. FDA approved medications for opioid dependence
B. Medications in schedules III, IV, or V
C. Buprenorphine and naloxone
D. Buprenorphine and methadone
D. Buprenorphine and methadone
The affinity of the buprenorphine results in:
A. A very strong bond to the opioid receptor
B. Displacement of buprenorphine by methadone
C. A prolonged bonding to the opioid receptor
D. An enhanced euphoric effect of buprenorphine
A. A very strong bond to the opioid receptor
, In taking a patient history the clinician should:
A. Maintain a confrontational stance to get honest answers
B. Assure patient that the objective is concern for their health
C. Not ask about other drug use as it will only create problems
D. Always have a release to talk to family members or support network
B. Assure patient that the objective is concern for their health
Moderate to severe opioid use disorder is different from simple physical
dependence because:
A. There is tolerance
B. There are withdrawal symptoms on discontinuation of the drug
C. There is compulsive use in the face of a variety of problems
D. Pain is the primary drive to continued use of the drug
C. There is compulsive use in the face of a variety of problems
Updated | Download to score A+
A 28-year-old man has had 3 supervised medical withdrawal treatments for
opioid addiction with relapses shortly after discharge. The treatment with the
strongest evidence of effective ent would be:
A. Therapeutic community
B. Intensive outpatient counseling
C. Medication Assisted Treatment (MAT)
D. Medical withdrawal from opioids
C. Medication Assisted Treatment (MAT)
The DATA 2000 law allows for the prescriptions of all of the following except:
A. FDA approved medications for opioid dependence
B. Medications in schedules III, IV, or V
C. Buprenorphine and naloxone
D. Buprenorphine and methadone
D. Buprenorphine and methadone
The affinity of the buprenorphine results in:
A. A very strong bond to the opioid receptor
B. Displacement of buprenorphine by methadone
C. A prolonged bonding to the opioid receptor
D. An enhanced euphoric effect of buprenorphine
A. A very strong bond to the opioid receptor
, In taking a patient history the clinician should:
A. Maintain a confrontational stance to get honest answers
B. Assure patient that the objective is concern for their health
C. Not ask about other drug use as it will only create problems
D. Always have a release to talk to family members or support network
B. Assure patient that the objective is concern for their health
Moderate to severe opioid use disorder is different from simple physical
dependence because:
A. There is tolerance
B. There are withdrawal symptoms on discontinuation of the drug
C. There is compulsive use in the face of a variety of problems
D. Pain is the primary drive to continued use of the drug
C. There is compulsive use in the face of a variety of problems
